Publications

• Allergen immunotherapy for insect venom allergy: a systematic review and metaanalysis.
  Dhami S et al.
  Allergy. 2017 Mar;72(3):342-365. doi: 10.1111/all.13077. Epub 2017 Jan 25.

• Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta analysis.
  Nurmatov U et al.
  Allergy. 2017 Jan 6. doi: 10.1111/all.13124.  

• Allergen immunotherapy for insect venom allergy: protocol for a systematic review.
  Dhami S et al.
  Clin Transl Allergy. 2016 Feb 16;6:6. doi: 10.1186/s13601-016-0095-x. eCollection 2015.

• Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review.
  Dhami S et al.
  Clin Transl Allergy. 2016 Jul 5;6:24. doi: 10.1186/s13601-016-0113-z. eCollection 2016.
  

• Allergen immunotherapy for allergic asthma: protocol for a systematic review.
  Dhami S et al.
  Clin Transl Allergy. 2016 Feb 9;6:5. doi: 10.1186/s13601-016-0094-y. eCollection 2015.
  

• Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.
  Dhami S et al.
  Clin Transl Allergy. 2016 Mar 22;6:12. doi: 10.1186/s13601-016-0099-6. eCollection 2016.  

• Vitamin D3 metabolite calcidiol primes human dendritic cells to promote the development of immunomodulatory IL-10-producing T cells.
  Bakdash G, van Capel TM1, Mason LM1, Kapsenberg ML1, de Jong EC.
  Vaccine. 2014 Sep 16. pii: S0264-410X(14)01239-0. doi: 10.1016/j.vaccine.2014.08.075. [Epub ahead of print]

• Vitamin D receptor agonists as anti-inflammatory agents.
  Adorini L, Amuchastegui S, Corsiero E, Laverny G, Le Meur T, Penna G.
  Expert Rev Clin Immunol. 2007 Jul;3(4):477-89. doi: 10.1586/1744666X.3.4.477

• 1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta.
  Taher YA, van Esch BC, Hofman GA, Henricks PA, van Oosterhout AJ.
  J Immunol. 2008 Apr 15;180(8):5211-21. 

• Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report.
  Burks AW, Calderon MA, Casale T, Cox L, Demoly P, Jutel M, Nelson H, Akdis
  J Allergy Clin Immunol. 2013 May;131(5):1288-96.e3. doi: 10.1016/j.jaci.2013.01.049. Epub 2013 Mar 14.
• The fold variant BM4 is beneficial in a therapeutic Bet v 1 mouse model.
  Pichler U, Asam C, Weiss R, Isakovic A, Hauser M, Briza P, Ferreira F, Wallner M.
  Biomed Res Int. 2013;2013:832404. doi: 10.1155/2013/832404. Epub 2013 Sep 23.

• A hypoallergenic variant of the major birch pollen allergen shows distinct characteristics in antigen processing and T-cell activation.
  Kitzmüller C, Wallner M, Deifl S, Mutschlechner S, Walterskirchen C, Zlabinger GJ, Ferreira F, Bohle B.
  Allergy. 2012 Nov;67(11):1375-82. doi: 10.1111/all.12016. Epub 2012 Sep 13.

• Reshaping the Bet v 1 fold modulates T(H) polarization.
  Wallner M, Hauser M, Himly M, Zaborsky N, Mutschlechner S, Harrer A, Asam C, Pichler U, van Ree R, Briza P, Thalhamer J, Bohle B, Achatz G, Ferreira F.
  J Allergy Clin Immunol. 2011 Jun;127(6):1571-8.e9. doi: 10.1016/j.jaci.2011.01.064. Epub 2011 Mar 21.

• Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases.
  Pfaar O, Bachert C, Bufe A, Buhl R, Ebner C, Eng P, Friedrichs F, Fuchs T, Hamelmann E, Hartwig-Bade D, Hering T, Huttegger I, Jung K, Klimek L, Kopp MV, Merk H, Rabe U, Saloga J, Schmid-Grendelmeier P, Schuster A, Schwerk N, Sitter H, Umpfenbach U, Wedi B, Wöhrl S, Worm M, Kleine-Tebbe J, Kaul S, Schwalfenberg A.
  Allergo J Int. 2014;23(8):282-319.

• Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivits: An EAACI Position Paper.
  Pfaar O, Demoly P, Gerth van Wijk R, Bonini S, Bousquet J, Canonica GW, Durham SR, Jacobsen L, Malling HJ, Mösges R, Papadopoulos NG, Rak S, Rodriguez del Rio P, Valovirta E, Wahn U, Calderon MA; European Academy of Allergy and Clinical Immunology.
  Allergy. 2014 Jul;69(7):854-67. doi: 10.1111/all.12383. Epub 2014 Apr 25.